Shitara, K. (2026). Reply to: Key Considerations for the Lenvatinib-Pembrolizumab-Chemotherapy Regimen in Advanced Gastric Cancer: Insights From LEAP-015. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02148